Newmark Named Exclusive Agent for 200 Atlantic Street, Hackensack’s Only Ground-Up Medical Office Building

August 7, 2025 9:00 AM

Newmark announces the company has been appointed as the exclusive leasing agent for 200 Atlantic Street, a newly constructed, Class A medical office building (“MOB”) in Hackensack, New Jersey. Newmark Managing Directors Dan Reider and Harrison Russell and Associates John Crawford and Jack Barclay are leading marketing and leasing efforts on behalf of owner and developer, Plaxsun Properties LLC.

“200 Atlantic Street is a rare opportunity: A true Class A, purpose-built medical space in a market where new inventory is nonexistent,” said Reider. “Its scale, infrastructure and immediate proximity to Hackensack University Medical Center make it uniquely positioned for practices seeking efficiency and visibility.”

The 51,750-square-foot property includes three floors of medical office space atop three levels of covered on-site parking. Designed specifically for healthcare users, the building features high-capacity HVAC and plumbing systems, multiple lobbies with elevator access, efficient floor plates and the opportunity for building signage. The building can accommodate users seeking up to 17,250 square feet, with divisibility options available.

The site offers direct access to one of the region’s leading hospitals, located directly across from the Hackensack University Medical Center campus. Prospective users benefit from access to Routes 17 and 80, two NJ Transit stations within walking distance and proximity to Teterboro and Newark Liberty airports.

The property is surrounded by a highly active medical community and a growing residential population, with over 5,000 new apartment units. Prospective users also benefit from proximity to Hackensack’s revitalized downtown, featuring new restaurants, retail and service amenities, all supporting increased foot traffic and convenience for both providers and patients.

About Plaxsun Properties LLC
Plaxsun Properties has been a family owned and operated commercial real estate company with a focus on development, since 1973, having successfully developed over two million square feet of corporate and medical real estate in Bergen County.

About Newmark
Newmark Group, Inc. (Nasdaq: NMRK), together with its subsidiaries (“Newmark”), is a world leader in commercial real estate, seamlessly powering every phase of the property life cycle. Newmark’s comprehensive suite of services and products is uniquely tailored to each client, from owners to occupiers, investors to founders, and startups to blue-chip companies. Combining the platform’s global reach with market intelligence in both established and emerging property markets, Newmark provides superior service to clients across the industry spectrum.  For the twelve months ended June 30, 2025, Newmark generated revenues of over $2.9 billion. As of June 30, 2025, Newmark and its business partners together operated from 165 offices with over 8,400 professionals across four continents. To learn more, visit nmrk.com or follow @newmark.

Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. These include statements about the Company’s business, results, financial position, liquidity, and outlook, which may constitute forward-looking statements and are subject to the risk that the actual impact may differ, possibly materially, from what is currently expected. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.